Form 4: United Therapeutics Director Ray Kurzweil Reports Stock Transactions
SEC Form 4 Filing
Director Ray Kurzweil reports the vesting of restricted stock units into common stock of United Therapeutics.
Summary
- On July 13, 2024, Ray Kurzweil, a director of United Therapeutics Corp, had 900 restricted stock units vest and convert into 900 shares of common stock.
- The transaction was reported on a Form 4 filing with the SEC.
- Following the transaction, Kurzweil directly owns 12,080 shares of United Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company director, with no particularly positive or negative implications.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 07/13/2024 | Date of transaction: vesting of restricted stock units and conversion to common stock. |
| 07/15/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.